These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Insulinotropic effects of hypoglycaemic and hyperglycaemic sulphonamides: the ionophoretic hypothesis. Couturier E; Malaisse WJ Diabetologia; 1980 Oct; 19(4):335-40. PubMed ID: 6253340 [TBL] [Abstract][Full Text] [Related]
4. Homologous and hybrid calcium complexes of A23187 and hypoglycemic sulfonylureas: nuclear magnetic resonance and conformational analysis. Deleers M; Brasseur R; Gelbcke M; Malaisse WJ J Inorg Biochem; 1982 Jun; 16(3):215-25. PubMed ID: 6809893 [TBL] [Abstract][Full Text] [Related]
5. The ability of a new hypoglycaemic agent, A-4166, compared to sulphonylureas, to increase cytosolic Ca2+ in pancreatic beta-cells under metabolic inhibition. Fujitani S; Okazaki K; Yada T Br J Pharmacol; 1997 Apr; 120(7):1191-8. PubMed ID: 9105692 [TBL] [Abstract][Full Text] [Related]
7. Calcium and stimulus secretion coupling in the neurohypophysis. V. The effects of the Ca2+ ionophores A23187 and X537 A on vasopressin release and 45Ca2+ efflux; interactions with sodium and a verapamil analogue (D600). Robinson IC; Russell JT; Thorn NA Acta Endocrinol (Copenh); 1976 Sep; 83(1):36-49. PubMed ID: 60866 [TBL] [Abstract][Full Text] [Related]
8. Protonophoretic activity of hypoglycemic sulfonylureas in black lipid membranes. Deleers M; Brasseur R Pharmacol Res Commun; 1986 Feb; 18(2):129-36. PubMed ID: 3010341 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of transglutaminase by hypoglycaemic sulphonylureas in pancreatic islets and its possible relevance to insulin release. Gomis R; Mathias PC; Lebrun P; Malaisse-Lagae F; Sener A; Malaisse WJ Res Commun Chem Pathol Pharmacol; 1984 Dec; 46(3):331-49. PubMed ID: 6151221 [TBL] [Abstract][Full Text] [Related]
10. Ionophoretic properties of the non-sulfonylurea hypoglycemic agents A-4166 and KAD-1229. Bakkali-Nadi A; Malaisse-Lagae F; Malaisse WJ Res Commun Mol Pathol Pharmacol; 1995 Jun; 88(3):339-47. PubMed ID: 8564389 [TBL] [Abstract][Full Text] [Related]
11. Ionophores X537A and A23187. Effects on the permeability of lipid bimolecular membranes to dopamine and calcium. Kafka MS; Holz RW Biochim Biophys Acta; 1976 Feb; 426(1):31-7. PubMed ID: 764880 [TBL] [Abstract][Full Text] [Related]
13. Synergism between two distinct ionophores in translocating calcium from an aqueous to an organic environment. Couturier E; Deleers M; Malaisse WJ Pharmacol Res Commun; 1980 Jul; 12(7):651-5. PubMed ID: 6773075 [No Abstract] [Full Text] [Related]
14. Differences between the effect of tolbutamide and Ca2+-ionophores on Ca2+ efflux from pancreatic beta-cells. Hellman B Pharmacol Res Commun; 1982 Sep; 14(8):701-10. PubMed ID: 6815668 [No Abstract] [Full Text] [Related]
15. Calcium ionophores A23187 and X537A affect cell agglutination by lectins and capping of lymphocyte surface immunoglobulins. Poste G; Nicolson GL Biochim Biophys Acta; 1976 Feb; 426(1):148-55. PubMed ID: 764879 [TBL] [Abstract][Full Text] [Related]
16. Suppression by 2-ketoisocaproate of the insulinotropic action of hypoglycemic sulfonylureas. Malaisse WJ; Mathias PC; Malaisse-Lagae F; Sener A Res Commun Chem Pathol Pharmacol; 1985 Feb; 47(2):265-84. PubMed ID: 3922019 [TBL] [Abstract][Full Text] [Related]
17. The stoichiometry of A23187- and X537A-mediated calcium ion transport across lipid bilayers. Blau L; Stern RB; Bittman R Biochim Biophys Acta; 1984 Nov; 778(1):219-23. PubMed ID: 6437447 [TBL] [Abstract][Full Text] [Related]
18. Pharmacology of the hypoglycaemic sulphonylurea gliquidone. III. Conformational analysis. Lins L; Brasseur R; Malaisse WJ Pharmacol Res; 1996; 34(1-2):9-10. PubMed ID: 8981549 [TBL] [Abstract][Full Text] [Related]